Axa S.A. Xenon Pharmaceuticals Inc. Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Axa S.A. holds 175,632 shares of XENE stock, worth $7.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

175,632

Previous 175,350 0.16%

Holding current value

$7.63 Million

Previous $5.88 Million 6.55%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$28.23 - $38.37 $7,960 - $10,820	282 Added 0.16%	175,632 $5.5 Million
Q1 2025 May 15, 2025	SELL	$33.55 - $40.74 $417,563 - $507,050	-12,446 Reduced 6.63%	175,350 $5.88 Million
Q4 2024 Feb 14, 2025	SELL	$38.14 - $45.74 $11,213 - $13,447	-294 Reduced 0.16%	187,796 $7.36 Million
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $1,878 - $2,285	52 Added 0.03%	188,090 $7.4 Million
Q2 2024 Feb 25, 2025	BUY	$36.25 - $43.75 $8,772 - $10,587	242 Added 0.13%	188,038 $7.33 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $6,017 - $7,262	166 Added 0.09%	188,038 $7.33 Million
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $2,175 - $2,552	51 Added 0.03%	187,872 $8.09 Million
Q4 2023 Jul 16, 2024	SELL	$28.7 - $46.46 $1,463 - $2,369	-51 Reduced 0.03%	187,821 $8.65 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $130,355 - $211,021	-4,542 Reduced 2.36%	187,821 $8.65 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $22,955 - $26,698	-672 Reduced 0.35%	192,363 $6.57 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $92,500 - $115,598	2,655 Added 1.39%	193,035 $7.43 Million
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $13,852 - $16,704	-414 Reduced 0.22%	190,380 $6.81 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $34,448 - $41,086	-1,042 Reduced 0.54%	190,794 $7.52 Million
Q3 2022 Feb 14, 2023	BUY	$30.79 - $39.82 $14,933 - $19,312	485 Added 0.25%	191,836 $6.93 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $14,933 - $19,312	485 Added 0.25%	191,836 $6.93 Million
Q2 2022 Feb 14, 2023	SELL	$25.44 - $35.16 $94,153 - $130,127	-3,701 Reduced 1.9%	191,351 $5.82 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $94,153 - $130,127	-3,701 Reduced 1.9%	191,351 $5.82 Million
Q1 2022 Feb 14, 2023	BUY	$25.09 - $33.13 $80,689 - $106,546	3,216 Added 1.68%	195,052 $5.96 Million
Q1 2022 May 13, 2022	BUY	$25.09 - $33.13 $100 - $132	4 Added 0.0%	195,052 $5.96 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $552,318 - $1.25 Million	35,405 Added 22.18%	195,048 $6.09 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $2.37 Million - $3.11 Million	159,643 New	159,643 $2.44 Million

Others Institutions Holding XENE

# of Institutions

223

Shares Held

72.7M

Call Options Held

336K

Put Options Held

309K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.7B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account